Genetic risk and clinical implications of BRCA1 and BRCA2 mutations in Turkish triple-negative breast cancer patients

Abstract Background Triple-negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Genetic mutations, particularly in BRCA1 and BRCA2, significantly influence its pathogenesis and clinical outcomes. Th...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Betul Celik Demirbas, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Zubeyde Yalniz Kayim, Ozge Pasin, Merve Cigdem Ozgel, Seref Bugra Tuncer
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Springer 2025-09-01
Sarja:	Discover Oncology
Aiheet:	BRCA1 and BRCA2 mutations Triple-negative breast cancer Genetic predisposition
Linkit:	https://doi.org/10.1007/s12672-025-03470-7
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!